← back to search

Bo Ai

Harbin Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Computational biology, Biology, Enhancer, Database, Chromatin, and Transcription factor.
h-index
citations
859
works
25
NIH funding
primary concept
email

Recent publications

Landscape and significance of human super enhancer-driven core transcription regulatory circuitry
Molecular Therapy — Nucleic Acids 2023cited by 21position: middledoi
SCInter: A comprehensive single-cell transcriptome integration database for human and mouse
Computational and Structural Biotechnology Journal 2023cited by 2position: middledoi
SEdb 2.0: a comprehensive super-enhancer database of human and mouse
Nucleic Acids Research 2022cited by 118position: middledoi
CRdb: a comprehensive resource for deciphering chromatin regulators in human
Nucleic Acids Research 2022cited by 13position: middledoi
Mechanism of N-Methyl-N-Nitroso-Urea-Induced Gastric Precancerous Lesions in Mice
Journal of Oncology 2022cited by 11position: middledoi
TRmir: A Comprehensive Resource for Human Transcriptional Regulatory Information of MiRNAs
Frontiers in Genetics 2022cited by 5position: middledoi
Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review
Recent Patents on Anti-Cancer Drug Discovery 2021cited by 31position: middledoi
OUP accepted manuscript
Nucleic Acids Research 2021cited by 22position: middledoi
Ginsenoside Rg3 Promotes Cell Growth Through Activation of mTORC1
Frontiers in Cell and Developmental Biology 2021cited by 15position: middledoi
TF-Marker: A comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human.
Zenodo (CERN European Organization for Nuclear Research) 2021cited by 14position: middledoi
TF-Marker: A comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human.
Zenodo (CERN European Organization for Nuclear Research) 2021cited by 10position: middledoi
Mechanism of Hypoxia-Activated MiR-194 /FoxO3a Inducing Glycolytic Metabolism Reprogramming in Gastric Precancerous Lesions
Research Square 2021cited by 2position: middledoi
ATACdb: a comprehensive human chromatin accessibility database
Nucleic Acids Research 2020cited by 74position: middledoi
VARAdb: a comprehensive variation annotation database for human
Nucleic Acids Research 2020cited by 44position: middledoi
MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer
Frontiers in Genetics 2020cited by 3position: middledoi
ENdb: a manually curated database of experimentally supported enhancers for human and mouse
Nucleic Acids Research 2019cited by 67position: middledoi
HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures
Briefings in Bioinformatics 2019cited by 13position: middledoi
SEdb: a comprehensive human super-enhancer database
Nucleic Acids Research 2018cited by 229position: middledoi
ce‐Subpathway: Identification of ce<scp>RNA</scp>‐mediated subpathways via joint power of ce<scp>RNA</scp>s and pathway topologies
Journal of Cellular and Molecular Medicine 2018cited by 9position: middledoi
Author Correction: The global view of mRNA-related ceRNA cross-talks across cardiovascular diseases
Scientific Reports 2018cited by 2position: middledoi
Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma
Oncogenesis 2017cited by 83position: middledoi
The global view of mRNA-related ceRNA cross-talks across cardiovascular diseases
Scientific Reports 2017cited by 35position: middledoi
Identification and analysis of a key long non‐coding RNAs (lncRNAs)‐associated module reveal functional lncRNAs in cardiac hypertrophy
Journal of Cellular and Molecular Medicine 2017cited by 15position: middledoi
Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways
Scientific Reports 2016cited by 13position: middledoi
RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method
Oncotarget 2016cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chunquan Li · Kunming University of Science and Technology20 papers (2016–2023)Chenchen Feng · Fudan University15 papers (2016–2023)Qiuyu Wang · Fudan University15 papers (2016–2023)Xuefeng Bai · Harbin Medical University13 papers (2016–2022)Jian Zhang · Shandong University of Science and Technology12 papers (2017–2023)Chao Song · Fudan University11 papers (2016–2022)Yuezhu Wang · Fudan University11 papers (2018–2023)Xuecang Li · Harbin Medical University10 papers (2016–2020)Yuejuan Liu · Harbin Medical University9 papers (2016–2022)Jun Zhao · Yunnan Academy of Agricultural Sciences8 papers (2020–2023)Fengcui Qian · Harbin Medical University8 papers (2018–2023)Mingcong Xu · Harbin Medical University7 papers (2019–2021)Guorui Zhang · Harbin Medical University6 papers (2020–2022)Qi Pan · IHI Corporation (United States)6 papers (2018–2020)Yong Jiang · Georgetown University6 papers (2018–2023)Xiaole Han · Harbin Medical University6 papers (2018–2020)Jiang Zhu · Chinese PLA General Hospital6 papers (2020–2023)Li‐Wei Zhou · Nantong University5 papers (2021–2022)Fan Wang · St. Jude Children's Research Hospital5 papers (2018–2022)Jiaxin Chen · Shihezi University4 papers (2020–2021)